PAM
ALNA

Panagora Asset Management’s Allena Pharmaceuticals ALNA Stock Holding History

Panagora Asset Management’s Portfolio ALNA Stock Details ALNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-777
Closed -$3K – 2621
2019
Q3 		$3K Buy
+777
New +$3.33K ﹤0.01% 2358

Other funds holding ALNA

FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
TGI
TRV GP II Boston, Massachusetts $1.34M AUM 67.55% 1-Year Est. Return
DVC
Deer VII & Co Larchmont, New York $317M AUM 30.89% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PIM
Partner Investment Management San Francisco, California $13.9M AUM 55.92% 1-Year Est. Return

Panagora Asset Management's ALNA Position: Q4 2019 in Review

Panagora Asset Management sold out of Allena Pharmaceuticals (ALNA) in Q4 2019, closing a stake of 777 shares — an estimated $3K sold.

Panagora Asset Management first reported a position in ALNA in Q3 2019 and held it in 1 quarter. The position peaked at $3K in Q3 2019. 26 funds tracked by Wall St. Rank hold ALNA as of Q4 2019.

  • Panagora Asset Management reported no remaining Allena Pharmaceuticals position as of Q4 2019 after selling out during the quarter.
  • Panagora Asset Management sold 777 Allena Pharmaceuticals shares in Q4 2019, an estimated $3K.
  • Panagora Asset Management first reported a position in Allena Pharmaceuticals in Q3 2019 and held it in 1 quarter.
  • Panagora Asset Management's Allena Pharmaceuticals position peaked at $3K in Q3 2019.
  • 26 funds tracked by Wall St. Rank held Allena Pharmaceuticals as of Q4 2019.

Based on Panagora Asset Management's 13F filing for Q4 2019, filed 12 Feb 2020.